{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T09:14:30Z","timestamp":1783502070420,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.clon.2018.11.033","type":"journal-article","created":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T08:02:22Z","timestamp":1544256142000},"page":"250-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Variation in the Use of Boost Irradiation in Breast-Conserving Therapy in the Netherlands: The Effect of a National Guideline and Cofounding Factors"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4224-800X","authenticated-orcid":false,"given":"K.","family":"Schreuder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H.","family":"Maduro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.E.R.","family":"Spronk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Bijker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.P.","family":"Poortmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"van Dalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Struikmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Siesling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2018.11.033_bib1","series-title":"NABON breast cancer Audit","year":"2015"},{"key":"10.1016\/j.clon.2018.11.033_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1470-2045(14)71156-8","article-title":"Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial","volume":"16","author":"Bartelink","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2018.11.033_bib3","first-page":"395","article-title":"Is there an indication for additional local irradiation in conserving treatment of breast cancer patients aged 60 and over?","volume":"146","author":"Noordijk","year":"2002","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.clon.2018.11.033_bib4","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1200\/JCO.2007.11.4991","article-title":"Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial","volume":"25","author":"Bartelink","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2018.11.033_bib5","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJMoa010874","article-title":"Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation","volume":"345","author":"Bartelink","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clon.2018.11.033_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.radonc.2008.07.011","article-title":"Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial","volume":"90","author":"Poortmans","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2018.11.033_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.clon.2008.12.008","article-title":"Early and locally advanced breast cancer: diagnosis and treatment National Institute for Health and Clinical Excellence guideline 2009","volume":"21","author":"Yarnold","year":"2009","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2018.11.033_bib8","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.clon.2005.11.008","article-title":"Placing the boost in breast-conservation radiotherapy: a review of the role, indications and techniques for breast-boost radiotherapy","volume":"18","author":"Graham","year":"2006","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2018.11.033_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jamaoncol.2016.3031","article-title":"Prognostic factors for local control in breast cancer after long-term follow-up in the EORTC boost vs no boost trial: a randomized clinical trial","volume":"3","author":"Vrieling","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clon.2018.11.033_bib10","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/annonc\/mds066","article-title":"Long-term cosmetic changes after breast-conserving treatment of patients with stage I-II breast cancer and included in the EORTC 'boost versus no boost' trial","volume":"23","author":"Immink","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2018.11.033_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.radonc.2004.03.007","article-title":"The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial","volume":"72","author":"Poortmans","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2018.11.033_bib12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.radonc.2010.01.009","article-title":"Dutch Young Boost Study, van Vliet-Vroegindeweij C. Multi-institutional study on target volume delineation variation in breast radiotherapy in the presence of guidelines","volume":"94","author":"van Mourik","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2018.11.033_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00066-012-0300-3","article-title":"Is the simultaneously integrated boost (SIB) technique for early breast cancer ready to be adopted for routine adjuvant radiotherapy? Statement of the German and the Austrian Societies of Radiooncology (DEGRO\/OGRO)","volume":"189","author":"Sedlmayer","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.clon.2018.11.033_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1748-717X-9-36","article-title":"Breast conserving treatment for breast cancer: dosimetric comparison of different non-invasive techniques for additional boost delivery","volume":"9","author":"Van Parijs","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clon.2018.11.033_bib15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00066-016-1025-5","article-title":"Second cancer risk after simultaneous integrated boost radiation therapy of right sided breast cancer with and without flattening filter","volume":"192","author":"Dobler","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.clon.2018.11.033_bib16","first-page":"472516","article-title":"Boost IORT in breast cancer: body of evidence","author":"Sedlmayer","year":"2014","journal-title":"Int J Breast Cancer"},{"key":"10.1016\/j.clon.2018.11.033_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1586\/17434440.2014.882653","article-title":"Intraoperative radiation therapy techniques and options for breast cancer","volume":"11","author":"Kalakota","year":"2014","journal-title":"Expert Rev Med Dev"},{"key":"10.1016\/j.clon.2018.11.033_bib18","first-page":"353","article-title":"Tumor bed boost radiotherapy in breast cancer. A review of current techniques","volume":"33","author":"Bahadur","year":"2012","journal-title":"Saudi Med J"},{"key":"10.1016\/j.clon.2018.11.033_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijrobp.2014.09.024","article-title":"High-dose-rate brachytherapy boost effect on local tumor control in young women with breast cancer","volume":"91","author":"Guinot","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2018.11.033_bib20","doi-asserted-by":"crossref","first-page":"294","DOI":"10.5114\/jcb.2016.61973","article-title":"External beam boost versus interstitial high-dose-rate brachytherapy boost in the adjuvant radiotherapy following breast-conserving therapy in early-stage breast cancer: a dosimetric comparison","volume":"8","author":"Terheyden","year":"2016","journal-title":"J\u00a0Contemp Brachytherapy"},{"key":"10.1016\/j.clon.2018.11.033_bib21","series-title":"Primaire locoregionale behandeling van stadium I-II","year":"2008"},{"issue":"559","key":"10.1016\/j.clon.2018.11.033_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3399\/bjgp09X395076","article-title":"Factors influencing variation in prescribing of antidepressants by general practices in Scotland","volume":"59","author":"Morrison","year":"2009","journal-title":"Br J Gen Pract"},{"issue":"1","key":"10.1016\/j.clon.2018.11.033_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191943","article-title":"Practice variation and practice guidelines: attitudes of generalist and specialist physicians, nurse practitioners, and physician assistants","volume":"13","author":"Cook","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.clon.2018.11.033_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10549-017-4232-6","article-title":"Omitting re-excision for focally positive margins after breast-conserving surgery does not impair disease-free and overall survival","volume":"164","author":"Vos","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clon.2018.11.033_bib25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejca.2016.05.010","article-title":"Contemporary risks of local and regional recurrence and contralateral breast cancer in patients treated for primary breast cancer","volume":"63","author":"Aalders","year":"2016","journal-title":"Eur J Cancer"},{"issue":"18","key":"10.1016\/j.clon.2018.11.033_bib26","doi-asserted-by":"crossref","first-page":"07","DOI":"10.1200\/JCO.2015.64.3536","article-title":"Contemporary locoregional recurrence rates in young patients with early-stage breast cancer","volume":"34","author":"Aalders","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2018.11.033_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4048\/jbc.2013.16.1.97","article-title":"Validation of a web-based tool to predict the ipsilateral breast tumor recurrence (IBTR! 2.0) after breast-conserving therapy for Korean patients","volume":"16","author":"Jung","year":"2013","journal-title":"J\u00a0Breast Cancer"},{"key":"10.1016\/j.clon.2018.11.033_bib28","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jamainternmed.2016.4426","article-title":"Physician-driven variation in nonrecommended services among older adults diagnosed with cancer","volume":"176","author":"O'Connor","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.clon.2018.11.033_bib29","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.ejso.2015.07.011","article-title":"The influence of simultaneous integrated boost, hypofractionation and oncoplastic surgery on cosmetic outcome and PROMs after breast conserving therapy","volume":"41","author":"Lansu","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clon.2018.11.033_bib30","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1200\/JCO.2008.21.5764","article-title":"Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial","volume":"27","author":"Jones","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2018.11.033_bib31","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/bjs.4206","article-title":"Risk factors for local recurrence after breast-conserving surgery","volume":"90","author":"Fredriksson","year":"2003","journal-title":"Br J Surg"},{"key":"10.1016\/j.clon.2018.11.033_bib32","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1001\/archsurg.1994.01420330066013","article-title":"Margin status and local recurrence after breast-conserving surgery","volume":"129","author":"Spivack","year":"1994","journal-title":"Arch Surg"},{"key":"10.1016\/j.clon.2018.11.033_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jnci\/87.1.19","article-title":"Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events","volume":"87","author":"Veronesi","year":"1995","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clon.2018.11.033_bib34","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/annonc\/mdx308","article-title":"De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer","volume":"28","author":"Curigliano","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2018.11.033_bib35","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","article-title":"Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ \u2013 The LORD study","volume":"51","author":"Elshof","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clon.2018.11.033_bib36","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jamaoncol.2016.6948","article-title":"Association of radiotherapy boost for ductal carcinoma in situ with local control after whole-breast radiotherapy","volume":"3","author":"Moran","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clon.2018.11.033_bib37","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S1470-2045(06)70765-3","article-title":"Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network","volume":"7","author":"Omlin","year":"2006","journal-title":"Lancet Oncol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655518305296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655518305296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:45:37Z","timestamp":1760543137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655518305296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0936655518305296"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2018.11.033","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variation in the Use of Boost Irradiation in Breast-Conserving Therapy in the Netherlands: The Effect of a National Guideline and Cofounding Factors","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2018.11.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}